Related Experiment Video
Updated: Jun 18, 2026

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
Published on: January 2, 2026
Conservative management of pancreatic pseudocysts in children with acute lymphoblastic leukemia
Holly L Spraker1, Georgios P Spyridis, Ching-Hon Pui
1Department of Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA. holly.spraker@stjude.org
Insights
Asparaginase treatment for acute lymphoblastic leukemia can lead to pancreatitis and pseudocysts. Nonsurgical management is safe for these pediatric patients, allowing chemotherapy continuation and eventual oral feeding.
Area of Science:
- Pediatric Oncology
- Gastroenterology
- Hematology
Background:
- Asparaginase is a critical chemotherapeutic agent for acute lymphoblastic leukemia (ALL).
- Asparaginase therapy is associated with a risk of developing acute pancreatitis.
- Pancreatitis complications, such as pancreatic pseudocysts, can significantly impact patient management.
Observation:
- This report details five pediatric patients with ALL who developed acute pancreatitis with pseudocyst formation during asparaginase treatment.
- These patients required adjustments to their chemotherapy schedules and extended parenteral nutrition.
- No surgical interventions were necessary for the management of the pancreatic pseudocysts.
Findings:
- All five patients achieved first remission and survived.
- Pancreatic pseudocysts resolved spontaneously over 3 to 37 months or showed continued size reduction.
- Oral feeding was successfully reintroduced after the acute pancreatitis resolved, even with persistent pseudocysts.
Implications:
- Nonsurgical management of pancreatic pseudocysts in pediatric ALL patients is a safe and effective approach.
- Pseudocyst resolution can be a lengthy process, requiring patience and monitoring.
- Early reintroduction of oral feeding is feasible and beneficial for patients recovering from pancreatitis-induced pseudocysts.
Abstract:
Treatment with asparaginase for acute lymphoblastic leukemia can cause acute pancreatitis. Complication of pancreatitis by pancreatic pseudocyst formation can prolong the hospital stay, delay chemotherapy, and necessitate long-term parenteral nutrition. We report 5 children with acute lymphoblastic leukemia who developed acute pancreatitis complicated by pancreatic pseudocysts. They required modifications to their chemotherapy regimen and prolonged parenteral nutrition but no surgical intervention. All 5 patients survive in first remission and their pseudocysts resolved after 3 to 37 months or continued to decrease in size at last follow-up. These cases illustrate that nonsurgical management of pancreatic pseudocyst is safe, though pseudocyst resolution may require many months. In addition, these patients demonstrate that oral feeding can be initiated after the acute episode of pancreatitis resolves even if a pseudocyst is present.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management